Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06102200 · ClinicalTrials.gov registry record · NA
An Integrated Intervention Involving Recovery Coaching and Cognitive Behavioral Therapy for Opioid Use Disorder
A NA study, sponsored by Prisma Health-Upstate.
- Completed
- Registry status
- NA
- Development phase
- 92
- Enrollment target
NCT06102200 is a NA study that has completed, run by Prisma Health-Upstate. The registered enrollment target is 92 participants.
The verdict
NCT06102200, a NA study, has completed, sponsored by Prisma Health-Upstate.
- COMPLETED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
Study Summary
The Overcome II study is a randomized controlled trial among adults receiving sublingual buprenorphine to help prevent or reduce illicit drug use. The study outcomes will be compared between three treatment arms: (1) sublingual buprenorphine only, which is the standard-of-treatment (2) sublingual buprenorphine with a computer-based cognitive behavior therapy for substance use disorders (CBT4CBT), (3) sublingual buprenorphine with CBT4CBT and peer recovery coaching. The primary outcome of interest is the reduction in the proportion of positive results for saliva toxicology screenings for any drug during the 8-week treatment period. Study participants will also be assessed for the outcomes of retention to standard-of-treatment and illicit drug use at 1-, 3-, and 6-months follow-ups after the end of treatment.
Interventions
- BEHAVIORAL CBT4CBT
- BEHAVIORAL RC
- BEHAVIORAL Sandard of care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2023-10-05 |
| Est. Completion | 2025-12-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06102200
The ClinicalTrials.gov registry entry for NCT06102200 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Prisma Health-Upstate, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which CBT4CBT is the first listed.
NCT06102200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06102200 about?
NCT06102200 is a clinical study titled "An Integrated Intervention Involving Recovery Coaching and Cognitive Behavioral Therapy for Opioid Use Disorder". The Overcome II study is a randomized controlled trial among adults receiving sublingual buprenorphine to help prevent or reduce illicit drug use. The study outcomes will be compared between three treatment arms: (1) sublingual buprenorphine only, which is the standard-of-treatment (2) sublingual bu...
What is the current status of trial NCT06102200?
This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2023-10-05. Estimated completion is 2025-12-06.
What interventions are being tested in trial NCT06102200?
The interventions under investigation include: CBT4CBT (BEHAVIORAL), RC (BEHAVIORAL), Sandard of care (BEHAVIORAL).
Who is sponsoring clinical trial NCT06102200?
This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.